SEC Tracker
Get the app

Altair International PREM

Altair International Q1 FY25: revenue $5.9M, flat; diluted EPS $0.00

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Altair International reported for Q1 FY25, the quarter ended Mar 31, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$5.9MFlat against $5.9M in Q4 FY2410-Q income statement, on EDGAR
  2. Net income−$1.2M−2412% from $53K in Q4 FY2410-Q income statement, on EDGAR
  3. Diluted EPS$0.00Against $0.00 in Q4 FY2410-Q income statement, on EDGAR
  4. Cash and cash equivalents$147K+3311% from $4K in Q4 FY2410-Q balance sheet, on EDGAR
  5. Cash from operations$995K+178% from $358K in Q4 FY2410-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Altair International files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. QHSLab USAQ public float $2M, Jun 30, 2025
  2. Vycor Medical VYCO public float $2M, Jun 30, 2025
  3. Profusa PFSA public float $1M, Jun 30, 2025
  4. Semler Scientific SMLR
  5. INVO Fertility IVF public float $2M, Jun 30, 2025